There is one clinical trial.
The aim of this study is to evaluate the effectiveness of MLS laser therapy as a treatment for pulmonary complications due to COVID-19 infection.
Description: ICU on vent, ICU not requiring ventilation, Discharge to Rehab requiring assistance, Discharge to Home unable to perform ADL's, Discharge to Home able to perform ADL'sMeasure: Patient Disposition Post treatment Time: 7 days
Description: Patients oxygen requirements pulse oximetry will be evaluated for change from pre and post individual treatment as well as end of protocolMeasure: oxygenation Time: Daily for 4 days
Description: The change in pre treatment levels and 24 hours post final treatmentMeasure: IL-6 levels Time: First four days of trial
Description: Pre treatment CXR will be compared to post treatment CXR using the RALE CXR evaluation scaleMeasure: Chest Xray radiographic results Time: 7 Days
Description: The change in pretreatment and post treatment BCRSS will be evaluatedMeasure: Brescia-COVID Respiratory Severity Scale Time: 7 days
Description: The change in pretreatment and post treatment scores will be evaluatedMeasure: SMART-COP Score Time: 7 days
Description: The change in pretreatment and post treatment scores will be evaluatedMeasure: PSI Score Time: 7 days
Description: The change in pretreatment and post treatment levels will be evaluated The change in pretreatment and post treatment levels will be evalutatedMeasure: CRP levels Time: 7 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports